Möbus, V., Jackisch, C., Lueck, H., Du Bois, A., Thomssen, C., Kurbacher, C. M., . . . Schneeweiss, A. (2010). Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: Mature results of an AGO Phase III Study. Journal of clinical oncology, 28(17), . https://doi.org/10.1200/JCO.2009.24.7643
Chicago Style (17th ed.) CitationMöbus, Volker, Christian Jackisch, Hans-Joachim Lueck, Andreas Du Bois, Christoph Thomssen, Christian M. Kurbacher, Walther Kuhn, Ulrike Nitz, and Andreas Schneeweiss. "Intense Dose-dense Sequential Chemotherapy with Epirubicin, Paclitaxel, and Cyclophosphamide Compared with Conventionally Scheduled Chemotherapy in High-risk Primary Breast Cancer: Mature Results of an AGO Phase III Study." Journal of Clinical Oncology 28, no. 17 (2010). https://doi.org/10.1200/JCO.2009.24.7643.
MLA (9th ed.) CitationMöbus, Volker, et al. "Intense Dose-dense Sequential Chemotherapy with Epirubicin, Paclitaxel, and Cyclophosphamide Compared with Conventionally Scheduled Chemotherapy in High-risk Primary Breast Cancer: Mature Results of an AGO Phase III Study." Journal of Clinical Oncology, vol. 28, no. 17, 2010, https://doi.org/10.1200/JCO.2009.24.7643.